Our United Kingdom-based parent company, Johnson Matthey PLC, is a world leader in advanced materials technology, and has been a prime global player in the precious metals industry for more than 180 years.

    With facilities in 38 countries, the group manufactures pharmaceutical compounds; produces, refines, fabricates and markets precious metals and specialty chemicals; and manufactures catalysts, pollution control systems, decorative and specialized materials for the ceramic industry.

    Johnson Matthey Pharmaceuticals draws on the substantial technical resources of the Johnson Matthey Group, which spent35 Million on Research and Development last year. We seek partnerships with our customers in developing new products and we apply the latest technology in meeting and exceeding our customer's needs.

    Within our web-site, we have published our business unit and regulatory information, and contact details.